000088219 001__ 88219
000088219 005__ 20200716101450.0
000088219 0247_ $$2doi$$a10.1016/j.eimc.2019.02.003
000088219 0248_ $$2sideral$$a111296
000088219 037__ $$aART-2019-111296
000088219 041__ $$aspa
000088219 100__ $$aNabal Díaz, S.
000088219 245__ $$aArthrobacter creatinolyticus: un patógeno emergente en el ser humano causante de infecciones del tracto urinario
000088219 260__ $$c2019
000088219 5060_ $$aAccess copy available to the general public$$fUnrestricted
000088219 5203_ $$aArthrobacter creatinolyticus is a Gram-positive aerobic coccobacillus, catalase-positive, belonging to the family Micrococcaceae, order Actinomycetales, usually found in soil and in the environment. This organism produces urease, an extracellular enzyme with many industrial applications and a potential use in anti-cancer therapy due to its cytotoxic effect.1
We have only found in the literature one case of bacteremia due to this microorganism, and none confirmed as a cause of urinary tract infection. We present a case of urinary tract infection due to A. creatinolyticus.
A woman, in her ninety, came to the primary care with signs of agitation. The patient presented several pathologies as hypertension, diabetes, Parkinson''s disease and vascular dementia. She was aggressive at the time of consultation and the exploration was complicated as well as the anamnesis that was unable to stablish the presence of urethral syndrome. In addition no urine test strip or sediment analysis was done. The caregiver confirmed that the patient did not had fever but she had been agitated for the past four days. On the suspicion of urinary infection, the doctor ordered a urine culture and prescribed fosfomycin empirically. After 24 h of incubation in the chromogenic medium UTIR (Oxoid LTD, UK), >100, 000 CFU/mL of A. creatinolyticus were isolated (Fig. 1)...
000088219 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000088219 590__ $$a1.654$$b2019
000088219 591__ $$aMICROBIOLOGY$$b112 / 134 = 0.836$$c2019$$dQ4$$eT3
000088219 591__ $$aINFECTIOUS DISEASES$$b79 / 93 = 0.849$$c2019$$dQ4$$eT3
000088219 592__ $$a0.317$$b2019
000088219 593__ $$aMicrobiology (medical)$$c2019$$dQ3
000088219 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/acceptedVersion
000088219 700__ $$0(orcid)0000-0002-9582-5472$$aGarcía-Lechuz Moya, J.M.
000088219 700__ $$aMormeneo Bayo, S.
000088219 700__ $$aMillán Lou, M.I.
000088219 773__ $$g38, 2 (2019), 88-89$$pEnferm. infecc. microbiol. clín.$$tEnfermedades Infecciosas y Microbiologia Clinica$$x0213-005X
000088219 8564_ $$s140382$$uhttps://zaguan.unizar.es/record/88219/files/texto_completo.pdf$$yPostprint
000088219 8564_ $$s73274$$uhttps://zaguan.unizar.es/record/88219/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000088219 909CO $$ooai:zaguan.unizar.es:88219$$particulos$$pdriver
000088219 951__ $$a2020-07-16-09:06:08
000088219 980__ $$aARTICLE